13F HOLDINGS REPORT
CAXTON CORP
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0000919574-24-006599
Total Value
$24.2M
Positions
12
Other Managers
0
Confidential Omitted
Yes
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | XERIS BIOPHARMA HOLDINGS INC | XERS | 5,113,348 | $14.6M | 60.31% |
| 2 | REZOLUTE INC | RZLT | 1,318,967 | $6.4M | 26.47% |
| 3 | SPDR S&P 500 ETF TR | SPY | 2,867 | $1.6M | 6.81% |
| 4 | BERKSHIRE HATHAWAY INC DEL | BRK-A | 1,151 | $529,573 | 2.19% |
| 5 | BICARA THERAPEUTICS INC | BCAX | 10,941 | $278,669 | 1.15% |
| 6 | MIND MEDICINE MINDMED INC | 60255C885 | 34,073 | $193,876 | 0.80% |
| 7 | LEXEO THERAPEUTICS INC | LXEO | 17,851 | $161,374 | 0.67% |
| 8 | ABIVAX SA | AAVXF | 11,365 | $130,925 | 0.54% |
| 9 | KYVERNA THERAPEUTICS INC | KYTX | 22,981 | $112,378 | 0.47% |
| 10 | COMPASS THERAPEUTICS INC | CMPX | 43,465 | $79,976 | 0.33% |
| 11 | CONTEXT THERAPEUTICS INC | CNTX | 18,403 | $36,071 | 0.15% |
| 12 | ADICET BIO INC | ACET | 17,488 | $25,182 | 0.10% |